Ever Source Wealth Advisors, LLC Ironwood Pharmaceuticals Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 47 shares of IRWD stock, worth $88. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47Holding current value
$88% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IRWD
# of Institutions
238Shares Held
159MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$43 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$36.7 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$30.8 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$22.1 Million0.13% of portfolio
-
State Street Corp Boston, MA9.92MShares$18.6 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $288M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...